A shared −20 °C freezer, a labelled box, and two researchers drawing from the same stock is one of the most ordinary situations in a laboratory — and one of the easiest places for documentation to drift. One colleague writes “≥99% pure” in a notebook and moves on. The second borrows the same vial for a different in-vitro assay and inherits an assumption rather than a record. The purity figure is genuinely useful, but it answers a narrower question than most people assume. It describes how much of the detected signal belongs to the principal peak. It does not, by itself, tell you what that peak is. Identity testing is the evidence that closes the gap, and it matters most precisely when stock is shared.
What a Purity Percentage Can and Cannot Tell You
Purity in research peptide supply is typically expressed as a percentage derived from high-performance liquid chromatography (HPLC), and Research Sciences states that compounds are independently tested by HPLC with certificates of analysis (CoAs) covering purity and identity. The homepage at the time of writing advertises “≥99% Verified Purity” and “UK Research Materials Over 99.1% Purity”. Those are the shop’s published lines and are worth reconfirming on the live site. More importantly, the figure that applies to the vial in your hand is the one stated on its batch CoA, not the headline on a web page.
A purity percentage is a proportion. It tells you that the main peak dominates the chromatogram under the conditions used, which is a meaningful statement about the cleanliness of a preparation. It does not independently establish molecular identity, because chromatographic retention is a comparative measurement rather than a name. Related structures, truncated sequences or modified variants can behave in ways that a single percentage cannot resolve, which is why identity evidence is reported alongside purity rather than replaced by it.
Where identity evidence sits in the documentation
The testing framework is described as full-spectrum: purity, identity, heavy metals and endotoxin evaluation of submitted samples, with CoAs linked to supported products. The homepage lists “CoAs Janoshik Analytical Reports”, so a researcher opening a certificate should read it properly rather than treat it as a badge. Confirm that the document belongs to the batch in hand, that the identity field is populated, and that the purity value matches the number recorded in your notes. Where anything is unclear, query it using the reference printed on the vial before the material enters a study.
Two further details deserve attention. The FAQs state that all peptides contain trace amounts of mannitol, an excipient used to aid lyophilisation, stability and handling — a formulation fact that belongs in the batch record rather than in a shorthand description of the material. And packaging is not evidence: vial cap colours and other cosmetic features may vary between deliveries and are explicitly not indicators of identity, analytical quality or manufacturing origin.
Shared Stock, Shared Risk: Keeping the Vial and the Certificate in Step
When one person holds the stock and another uses it, trust transfers through paperwork, not memory. The moment a second researcher draws from the same box, the batch record has two authors and needs a single, unambiguous anchor.
The Internal Test Reference caveat
Restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or that they have undergone separate independent testing. For a lone researcher this is a footnote. For two colleagues pooling consumables it is the difference between a defensible record and an optimistic one. A second delivery with a familiar ITR is still a new batch record until the accompanying CoA has been opened and checked.
Labels, aliquots and storage
Vial labels use a reference format that combines the SKU code and expiry date — for example BPC10-03/27 — and that reference links to the corresponding CoA. Photograph the label on receipt, file the CoA under a matching filename, and quote the reference whenever documentation is queried. If material is split into secondary containers, the original label no longer travels with it: record the label reference, the date of transfer and the operator’s initials on every daughter vial. Lyophilised material should be held at −20 °C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided; reconstituted material is less stable and should be kept at 2–8 °C for short-term laboratory use only.
Mixtures need particular care. The shop does not supply blended peptides and recommends buying compounds individually and combining them only within a controlled experimental design. If a shared vial contains a combination, it exists because someone in the laboratory prepared it, and the identity evidence must be assembled from the component CoAs and the preparation record. All materials discussed here are for controlled laboratory and analytical research only — not for human or veterinary use, and not for therapeutic, clinical or diagnostic application.
Practical Habits for Two Researchers Working from One Batch
Intake is the first checkpoint. Orders are dispatched the next working day and shipped via Royal Mail Tracked 24, which usually delivers the following working day as a carrier estimate rather than a guarantee, so delivery times should be reconfirmed at checkout and in peak periods. When the parcel arrives, check vial labels against the order, file the CoA in a shared folder, and enter the reference in a stock sheet that both colleagues can see. Support is available for documentation questions, with the site advertising seven-day expert customer support.
Handling should follow one written workflow. Allow vials to reach ambient temperature before opening, work in a clean environment, and remove only the amount required for the experiment in progress. For in-vitro work, record the diluent volume and the target assay concentration in the shared record so that both researchers work from the same dilution scheme. The free reconstitution calculator covering mg, mcg, mL and U-100/U-50 scales is described for laboratory research use only and must never be used for human or veterinary dosing.
Reordering is a documentation decision as much as a purchasing one. Two people sourcing separately “for speed” is how a freezer box ends up holding material with two different ITRs and one set of notes. Whether you reach a catalogue directly or through a saved search for Uk peptides, choose on the basis that each batch arrives with a CoA you can file, a reference you can quote, and a domestic route that respects temperature-aware storage in transit. Research Sciences, described in its FAQs as the parent company of Imperial Peptides UK, publishes tracked domestic fulfilment and controlled storage as part of that supply model.
Finally, treat sign-out as part of the experiment. A simple sheet recording who removed material, the label reference, the date and the quantity taken gives the next person a trail from vial to certificate to result. Purchasers remain responsible for lawful use, safe handling, storage and disposal, for COSHH compliance and laboratory safety standards, and for confirming that a product suits the intended research application; orders inconsistent with the supplier’s compliance standards may be refused. Two names on a stock sheet are manageable. Two names on an undocumented vial are not.
